Get Your Red Envelopes Now | Qiming Venture Partners Releases Limited-Edition Year of the Horse Red Envelope Covers!
As we welcome the Year of the Horse, we're releasing a limited-edition red packet cover to thank you for your attention and support.
Gallop into Spring, Together on a New Journey
Qiming Venture Partners wishes you a prosperous and healthy Year of the Horse
On this occasion of the Bingwu New Year, we have a special gift for you
Introducing our limited-edition Year of the Horse red packet covers
Thank you for your attention and support
How to Use
Step 1: Click "Claim Qiming Venture Partners Red Packet Cover" below
Once claimed, you can use it unlimited times within the three-month validity period
Step 2: Enter a chat, tap the "+" button on the right
Select "Red Packet" to enter the "Send Red Packet" screen
Step 3: Select the "Qiming Venture Partners" red packet cover
Past Highlights
[Qiming Weekly · Portfolio News Top 10] Vol. 04, 2026.2.3
Qiming Venture Partners was founded in 2006. The firm currently manages 11 USD funds and 7 RMB funds, with total assets under management reaching $9.5 billion. It focuses on investing in outstanding early- and growth-stage companies in Technology and Healthcare.
To date, Qiming Venture Partners has invested in over 580 high-growth innovative companies, of which more than 210 have gone public on the New York Stock Exchange, NASDAQ, Hong Kong Exchanges and Clearing Limited, Shanghai Stock Exchange, and Shenzhen Stock Exchange, or exited through M&A and other means. More than 80 portfolio companies have become recognized unicorns or super-unicorns.
Many companies in Qiming Venture Partners' portfolio have grown into the most influential players in their respective fields, including Xiaomi (01810.HK), Meituan (03690.HK), Bilibili (NASDAQ:BILI, 09626.HK), Zhihu (NYSE:ZH, 02390.HK), Roborock (688169.SH), Hesai Technology (NASDAQ:HSAI, 02525.HK), UBTECH (09880.HK), WeRide (NASDAQ:WRD, 00800.HK), HyperStrong (688411.SH), Insta360 (688775.SH), Unisound (09678.HK), Biren Technology (06082.HK), Zhipu (02513.HK), Gan & Lee Pharmaceuticals (603087.SH), Tigermed (300347.SZ, 03347.HK), Zai Lab (NASDAQ:ZLAB, 09688.HK), CanSino Biologics (688185.SH, 06185.HK), Schrödinger (NASDAQ:SDGR), MicroPort EP MedTech (688617.SH), Sanyou Medical (688085.SH), Amoy Diagnostics (300685.SZ), SinoCellTech (688520.SH), Insilico Medicine (03696.HK), Argo Biomed, Yuanxin Technology, MediLink Therapeutics, LaNova Medicines, StepFun, and others.